Australia Stock Exchange release from NOXOPHARM : Noxopharm DARRT-2 Cancer Trial Update
13/12/2021 22:53
Australia Stock Exchange release from NOXOPHARM NOX.AX : Noxopharm DARRT-2 Cancer Trial Update
Recent news on Noxopharm
See all newsAustralia's Noxopharm hits three-month low on discounted placement
Brief: Noxopharm Receives Commitments For Placement
Brief: Noxopharm Requests Trading Halt Pending Material Capital Raising Announcement
Brief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential